GlaxoSmithKline Consumer Healthcare Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 19	Mar ' 18	Mar ' 17	Mar ' 16	Mar ' 15

Sources of funds

Owner's fund

Equity share capital

42.06

42.06

42.06

42.06

42.06

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

4,052.66

3,443.06

3,080.61

2,403.58

2,070.98

Loan funds

Secured loans

-

-

-

-

-

Unsecured loans

-

-

-

-

-

Total

4,094.71

3,485.12

3,122.67

2,445.63

2,113.04

Uses of funds

Fixed assets

Gross block

695.07

649.31

630.30

1,025.82

986.64

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

233.00

173.78

142.87

539.85

494.90

Net block

462.07

475.53

487.43

485.97

491.74

Capital work-in-progress

17.73

38.25

57.67

51.39

42.31

Investments

-

-

-

-

-

Net current assets

Current assets, loans & advances

5,588.29

4,898.88

4,415.08

3,961.44

3,485.49

Less : current liabilities & provisions

1,973.38

1,927.54

1,837.51

2,053.17

1,906.51

Total net current assets

3,614.91

2,971.34

2,577.57

1,908.27

1,578.98

Miscellaneous expenses not written

-

-

-

-

-

Total

4,094.71

3,485.12

3,122.67

2,445.63

2,113.04

Notes:

Book value of unquoted investments

-

-

-

-

-

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

152.78

144.86

156.22

158.34

631.60

Number of equity sharesoutstanding (Lacs)

420.56

420.56

420.56

420.56

420.56